We are committed to finding a cure for WM.

2017 Financials

 

                 Waldenstrom’s Macroglobulinemia Foundation of Canada

 

                                       2017 Financial Statements

 

                              Balance Sheet as at December 31, 2017

 

 

                                                     Assets                                           2016                            2017

 

Cash in Bank Accounts                                                                    $121,940                      $107,483

Short Term GIC                                                                                               0                        200,000

Research Grant Receivable (Note 4)                                                80,626                                   0            

Sales Tax Receivable                                                                               2,764                               412

Total Assets                                                                                          205,330                        307,895

 

                                                  Liabilities

 

Total Liabilities                                                                                      $0                                $509

 

                                                    Equity

 

Retained Earnings                                                                              $205,330                      $307,386

 

Total Liability and Retained Earnings                                              $205,330                     $307,895

 

 

Approved on behalf of the Board

 

Signed

  1. Hinchcliffe, Director and President
  2. R. Johnston, Director and Treasurer